A comparison of budesonide/formoterol [Symbicort] Turbuhaler 160/4.5 microg 2 inhalations BID [twice daily] plus as needed to budesonide [Pulmicort] Turbuhaler 320 microg 2 inhalations BID plus terbutaline [Bricanyl] Turbuhaler 0.4 mg as needed for the prevention of asthma relapse.

Trial Profile

A comparison of budesonide/formoterol [Symbicort] Turbuhaler 160/4.5 microg 2 inhalations BID [twice daily] plus as needed to budesonide [Pulmicort] Turbuhaler 320 microg 2 inhalations BID plus terbutaline [Bricanyl] Turbuhaler 0.4 mg as needed for the prevention of asthma relapse.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Budesonide; Budesonide/formoterol; Terbutaline
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PARADE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 01 Jan 2008 Status changed from in progress to completed.
    • 07 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top